A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Part of paid clinical trials in San Bernardino, California.
- Sponsor
- ModernaTX, Inc.
- Study ID
- NCT07496450
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Influenza
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- mRNA-1018-H5 — BIOLOGICALSterile liquid for injection.
- Placebo — BIOLOGICALSterile liquid for injection.
Study Details
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.
Key Dates
- Start date
- Mar 23, 2026
- Status verified
- Mar 2026
- Primary completion
- Jan 28, 2027
- Completion
- Jan 28, 2027
Study Design
- Enrollment
- 4,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: mRNA-1018-H5 VaccineParticipants will receive mRNA-1018-H5 vaccine by intramuscular (IM) injection on Day 1 and Day 22.
- Placebo Comparator: PlaceboParticipants will receive placebo matched to mRNA-1018-H5 vaccine by IM injection on Day 1 and Day 22.
Primary Outcome Measure
Percentage of Participants With Hemagglutination Inhibition (HAI) Titer ≥ 1:40 at Day 43 [ Time Frame: Day 43 ]
Central Contacts
- Moderna WeCare Team1-866-663-3762
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Velocity Clinical Research, San Bernardino | San Bernardino | California | 92408 | - |
| Velocity Clinical Research, Savannah | Savannah | Georgia | 31406 | - |
| Velocity Clinical Research, Boise | Meridian | Idaho | 83642 | - |
| Velocity Clinical Research, Rockville | Rockville | Maryland | 20854 | - |
| Velocity Clinical Research, Omaha | Omaha | Nebraska | 68134 | - |
| Velocity Clinical Research, Cleveland | Beachwood | Ohio | 44122 | - |
| Velocity Clinical Research, Providence | East Greenwich | Rhode Island | 02818 | - |
| Velocity Clinical Research, Anderson | Anderson | South Carolina | 29621 | - |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | - |
| Velocity Clinical Research, Suffolk | Suffolk | Virginia | 23435 | - |
Find similar trials in San Bernardino, CA
By research site
Velocity Clinical Research, San Bernardino· San Bernardino, CAVelocity Clinical Research, Savannah· Savannah, GAVelocity Clinical Research, Boise· Meridian, IDVelocity Clinical Research, Rockville· Rockville, MDVelocity Clinical Research, Omaha· Omaha, NEVelocity Clinical Research, Cleveland· Beachwood, OH
Related Studies
- Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Influenza Immunization in Adults Over Age 75Recruiting · Johns Hopkins University · Baltimore, Maryland
- Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Observational Digital Biomarker Discovery in Respiratory Virus Challenge StudiesRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland